VEGFA and myocardial infarction: Recently, a number of experimental studies have suggested that treatment with angiogenic growth factors can promote the development of collaterals in animal MI models [2–3], such as vascular endothelial growth factor (VEGF), an endothelial cell mitogen that is thought to function in angiogenesis [4].